Céfoxitine : interactions médicamenteuses
Céfoxitine (Mefoxin), céphalosporine, présente 63 interactions documentées dans les notices FDA et les fiches d'information que nous indexons : 27 de niveau majeur, 35 de niveau modéré, 1 de niveau mineur et 0 cas où une notice ne signale aucune interaction significative. Chaque entrée ci-dessous cite la phrase sur laquelle elle repose. Cette page consacrée à un médicament est un point de départ, pas un verdict sur votre situation.
Interactions d'après la notice
Interactions majeures (27)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (notice Ertapénem, Contre-indications)
Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (notice Imipénem et cilastatine, Mises en garde et précautions)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (notice Céfoxitine, Contre-indications)
Interactions modérées (35)
Ethacrynic acid may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics. (notice Acide étacrynique, Interactions médicamenteuses)
Aminoglycosides: Increased potential of nephrotoxicity. (notice Céfoxitine, Interactions médicamenteuses)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (notice Aztréonam, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
Cephalosporin Furosemide can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment. (notice Furosémide, Interactions médicamenteuses)
Aminoglycosides: Increased potential of nephrotoxicity. (notice Céfoxitine, Interactions médicamenteuses)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (notice Mycophénolate, Interactions médicamenteuses)
Aminoglycosides: Increased potential of nephrotoxicity. (notice Céfoxitine, Interactions médicamenteuses)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
Aminoglycosides: Increased potential of nephrotoxicity. (notice Céfoxitine, Interactions médicamenteuses)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
- ProbénécideModérée
Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (notice Probénécide, Interactions médicamenteuses)
- Probénécide et colchicineModérée
DRUG INTERACTIONS When probenecid is used to elevate plasma concentrations of penicillin, or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (notice Probénécide et colchicine, Interactions médicamenteuses)
- ProtamineModérée
Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (notice Protamine, Précautions)
Aminoglycosides: Increased potential of nephrotoxicity. (notice Céfoxitine, Interactions médicamenteuses)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (notice Céfoxitine, Mises en garde et précautions)
Mentions mineures (1)
Before initiating therapy with Meropenem for injection, it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens. (notice Méropénem, Mises en garde et précautions)
Vérifiez Céfoxitine avec tout ce que vous prenez. Ajoutez votre liste complète ; toutes les paires sont vérifiées en une fois.
Ouvrir dans le vérificateurCeci n'est pas un avis médical. Le niveau de gravité reflète la formulation de la notice, pas votre situation. Une alerte « majeure » peut être courante sous surveillance et une alerte « mineure » peut compter à forte dose. Demandez conseil à un pharmacien.